- Home
- BZH vs CRMD Comparison
BZH vs CRMD Comparison
Compare BZH & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BZH | CRMD |
|---|---|---|
| Founded | 1985 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 672.0M | 626.0M |
| IPO Year | 1995 | 2009 |
Fundamental Metrics
Financial Performance| Metric | BZH | CRMD |
|---|---|---|
| Price | $25.71 | $8.45 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $32.00 | $14.83 |
| AVG Volume (30 Days) | 898.7K | ★ 1.3M |
| Earning Date | 04-30-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 780.00 |
| EPS | N/A | ★ 0.43 |
| Revenue | ★ $2,087,739,000.00 | $311,709,000.00 |
| Revenue This Year | $4.36 | $0.30 |
| Revenue Next Year | $10.79 | N/A |
| P/E Ratio | ★ N/A | $19.59 |
| Revenue Growth | N/A | ★ 617.03 |
| 52 Week Low | $17.83 | $6.13 |
| 52 Week High | $28.33 | $17.43 |
Technical Indicators
Market Signals| Indicator | BZH | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 65.26 | 63.26 |
| Support Level | $24.18 | $6.14 |
| Resistance Level | $27.35 | $8.53 |
| Average True Range (ATR) | 1.17 | 0.38 |
| MACD | 0.38 | 0.05 |
| Stochastic Oscillator | 95.33 | 68.54 |
Price Performance
Historical ComparisonAbout BZH Beazer Homes USA Inc.
Beazer Homes USA Inc is an construction company that focuses on residential construction. The company specializes in single-family housing and multi-unit building construction in states and metro markets. Beazer Homes builds homes and communities that target first-time, move-up, and luxury homebuyers with an average selling price of roughly $300,000. From a geographic perspective, home sales in the western and eastern United States have been the sources of revenue for the company. Its segments involve: West segment that includes Arizona, California, Nevada, and Texas; East segment that includes Delaware, Indiana, Maryland, Tennessee, and Virginia; and Southeast segment which includes Florida, Georgia, North Carolina, and South Carolina.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.